Table 1.
Baseline characteristics of study participants and women living with HIV experiencing pregnancies and factors associated with pregnancy after HIV diagnosis.
| WLHIV Total | WLHIV experiencing pregnancies | Univariate | Multivariate | |||||
|---|---|---|---|---|---|---|---|---|
| N=498 | N=73 | OR | 95% CI | p | OR | 95% CI | p | |
| Median age at ART initiation (yr), median (IQR) | 30 (26–36) | 27 (24–30) | ||||||
| Age category at ART initiation (yr) | ||||||||
| ≤27 | 176 (35) | 40 (55) | 1 | 1 | ||||
| >27 | 322 (65) | 33 (45) | 0.39 | (0.23–0.64) | <0.001 | 0.40 | (0.24, 0.67) | <0.001 |
| HIV mode of exposure | ||||||||
| Heterosexual contact | 473 (95) | 72 (99) | 1 | |||||
| Injecting drug use | 11 (2) | 1 (1) | 0.56 | (0.07–4.42) | 0.580 | |||
| Other/Unknown | 14 (3) | 0 (0) | N/A | |||||
| CD4 (cells/μL) at ART initiation, n (%) | 0.077 | |||||||
| ≤50 | 114 (23) | 8 (11) | 0.34 | (0.15– 0.77) | 0.009 | |||
| 51–100 | 38 (8) | 5 (7) | 0.68 | (0.25–1.88) | 0.460 | |||
| 101–200 | 90 (18) | 13 (18) | 0.76 | (0.38–1.53) | 0.443 | |||
| >200 | 176 (35) | 32 (44) | 1 | |||||
| Not reported | 80 (16) | 15 (21) | ||||||
| Viral load (copies/mL) at ART initiation, n (%) | 0.009 | 0.010 | ||||||
| ≤50,000 | 204 (41) | 39 (53) | 1 | 1 | ||||
| 50,001–250,000 | 117 (23) | 15 (21) | 0.62 | (0.33–1.19) | 0.149 | 0.60 | (0.31–1.15) | 0.126 |
| >250,000 | 73 (15) | 2 (3) | 0.12 | (0.03– 0.51) | 0.004 | 0.13 | (0.03–0.54) | 0.005 |
| Not done | 104 (21) | 17 (23) | ||||||
| Ever had a CDC-C diagnosis, n (%) | ||||||||
| No | 345 (69) | 59 (81) | 1 | |||||
| Yes | 152 (31) | 14 (19) | 0.49 | (0.27–0.91) | 0.024 | |||
CDC-C indicates US Centers for Disease Control and Prevention clinical category C; CI, confidence interval; OR, odds ratio